As per the research conducted by GME, the At-Home COVID-19 Testing Market will grow with
a CAGR value of 8.2 percent. The rapidly increasing COVID-19 positive cases,
increasing pressure on social distancing at public places, increasing demand
for the home-based minimally invasive confirmatory test, and rising need for
cost curbing for the pre-infection diagnosis will help the market growth
positively.
Browse 151 Market Data
Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global At-Home
COVID-19 Testing Market - Forecast to
2026"
https://www.globalmarketestimates.com/market-report/global-at-home-covid-19-testing-market-2911
By
Type of Product (At-Home Testing Kit and At-Home Collection Kit), By
Availability (Over the Counter, and Prescription Based), By Age Group for
At-Home Testing Kit (Age 2 & Above, Age 8 & Above, and Age 14 &
Above), By Testing Technology (Molecular/ PCR/ RNA Test, Antigen Test, and
Antibody Test), By Turnaround Time (10 Minutes TAT, 15 Minutes TAT, and 30
Minutes TAT), By Sample Type for At-Home Testing Kit (Nasopharyngeal &
Throat Swab, and Blood Test), By Sample Type for At-Home Collection Kit (Nasal
or Cheek Swab Test, and Saliva Test) By End-User (Home Use, and Commercial Use),
By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and
Africa); End-User Landscape, Company Market Share Analysis, and Competitor
Analysis
Key
Market Insights
·
The market for the at-home testing kit will be
growing faster than the collection kit owing to advantages over the at-home
collection kit
·
The market for this segment is ought to be the
largest in terms of market value or revenue sales from 2021 to 2026
·
The high accuracy technology for detection
confirmatory presence of COVID-19 infection is the molecular/ PCR/ RNA test
which will gain more traction than other tests
·
Cue Health, Quidel, Abbott, Lucira, Ellume, SD
Biosensor, Roche, Bione, Bosch, Vitagene, Vault Health, 1Health.io, Phosphorus
Diagnostics, Everlywell, PrivaPath Diagnostics, LabCorp, Fulgent Genetics,
Spectrum Solutions, Detect, and Quest Diagnostics among others are the players
in the at-home COVID-19 testing market
Browse the Report @ https://www.globalmarketestimates.com/market-report/global-at-home-covid-19-testing-market-2911
Type of Product Outlook (Revenue, USD Billion,
2021-2026)
·
At-Home Testing Kit
·
At-Home Collection Kit
Availability
Outlook (Revenue, USD Billion, 2021-2026)
·
Over the Counter
·
Prescription Based
Age
Group for At-Home Testing Kit Outlook (Revenue, USD Billion, 2021-2026)
·
Age 2 & Above
·
Age 8 & Above
·
Age 14 & Above
Testing
Technology Outlook (Revenue, USD Billion, 2021-2026)
·
Molecular/ PCR/ RNA Test
·
Antigen Test
·
Antibody Test
Turnaround
Time Outlook (Revenue, USD Billion, 2021-2026)
·
10 Minutes TAT
·
15 Minutes TAT
·
30 Minutes TAT
Age
Group for At-Home Testing Kit Outlook (Revenue, USD Billion, 2021-2026)
·
Age 2 & Above
·
Age 8 & Above
·
Age 14 & Above
Sample
Type for At-Home Testing Kit Outlook (Revenue, USD Billion, 2021-2026)
·
Nasopharyngeal & Throat Swab
·
Blood Test
Sample
Type for At-Home Collection Kit Outlook (Revenue, USD Billion, 2021-2026)
·
Nasal or Cheek Swab Test
·
Saliva Test
End-Users
Outlook (Revenue, USD Billion, 2021-2026)
·
Home Use
·
Commercial Use
Regional Outlook
(Revenue, USD Billion, 2021-2026)
North America
- The
U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of
Europe
Asia Pacific
- China
- India
- Japan
- South
Korea
- Australia
- Rest of
APAC
Central
& South America
- Brazil
- Argentina
- Rest of
CSA
Middle
East & Africa
- Saudi
Arabia
- UAE
- Rest of
MEA
Contact:
Tracy Simon
Email address: tracy.simon@globalmarketestimates.com
Phone
Number: +16026667238
Website:
https://www.globalmarketestimates.com/
Check
our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php
No comments:
Post a Comment